Advertisement
Screener

Quest Diagnostics Inc (DGX) Equity Securities, FV-NI, Gain (Loss)

1.9 / 5 stars · 46/120 Roast Me

Quest Diagnostics Inc Equity Securities, FV-NI, Gain (Loss)

Quest Diagnostics Inc (DGX) reported Equity Securities, FV-NI, Gain (Loss) of $19.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Income Statement › Other Income

us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-02-26

  • Quest Diagnostics Inc equity securities, fv-ni, gain (loss) for the quarter ending 2021-09-30 was $42.00M.
  • Quest Diagnostics Inc equity securities, fv-ni, gain (loss) for fiscal 2025 was $19.00M, a 5.56% increase from fiscal 2024.
  • Quest Diagnostics Inc equity securities, fv-ni, gain (loss) for fiscal 2024 was $18.00M, a 10.00% decline from fiscal 2023.
  • Quest Diagnostics Inc equity securities, fv-ni, gain (loss) for fiscal 2023 was $20.00M.
  • Quest Diagnostics Inc equity securities, fv-ni, gain (loss) for fiscal 2022 was -$55.00M, a 198.21% decline from fiscal 2021.
Period endEquity Securities, FV-NI, Gain (Loss) 3 monthEquity Securities, FV-NI, Gain (Loss) 12 month
2025-12-31$19.00M
10-K · filed 2026-02-26
2024-12-31$18.00M
10-K · filed 2026-02-26
2023-12-31$20.00M
10-K · filed 2026-02-26
2022-12-31-$55.00M
10-K · filed 2025-02-20
2021-12-31$56.00M
10-K · filed 2024-02-22
2021-09-30$42.00M
10-Q · filed 2021-10-22
2020-12-31$8.00M
10-K · filed 2023-02-21
2019-12-31$10.00M
10-K · filed 2022-02-28
2018-12-31-$2.00M
10-K · filed 2021-02-22
2017-12-31$8.00M
10-K · filed 2020-02-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30